Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sang Baek Ryu, Ph.D.

Concepts (78)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms3201613510.190 Why?
Phthalazines120203610.150 Why?
Ovarian Neoplasms5202048230.150 Why?
Genes, BRCA2120206170.140 Why?
Genes, BRCA1120207800.140 Why?
Lymph Nodes2201634650.120 Why?
Carcinoma, Endometrioid120162710.110 Why?
Germ-Line Mutation1202017860.100 Why?
Uterine Cervical Neoplasms3201520110.090 Why?
Water Movements12009170.090 Why?
Genital Neoplasms, Female120155160.090 Why?
Piperazines1202024880.090 Why?
Water Microbiology120091170.080 Why?
Neoplasms, Glandular and Epithelial120134840.080 Why?
Lymphatic Metastasis1201629060.080 Why?
Neoplasm Recurrence, Local4202091850.070 Why?
Camptothecin120085720.060 Why?
Ovary120099810.060 Why?
Antineoplastic Agents, Phytogenic120086230.060 Why?
Neoplasms, Germ Cell and Embryonal120094840.060 Why?
CA-125 Antigen220162790.050 Why?
Republic of Korea220165380.050 Why?
Pelvis220167300.050 Why?
Models, Statistical2201351000.050 Why?
Antineoplastic Combined Chemotherapy Protocols22020114720.050 Why?
Lymph Node Excision2201612480.050 Why?
Platinum Compounds12020960.040 Why?
Models, Biological2201295810.040 Why?
Gynecologic Surgical Procedures220133360.040 Why?
Preoperative Period120165460.030 Why?
Uterus120167100.030 Why?
Oligohymenophorea1200910.020 Why?
Principal Component Analysis120139390.020 Why?
Neoplasm Staging22016110010.020 Why?
Oceans and Seas12009500.020 Why?
Hysterectomy120169270.020 Why?
Middle Aged820202131270.020 Why?
Adult820202137120.020 Why?
Korea12009990.020 Why?
Aged, 80 and over32020576830.020 Why?
Topoisomerase I Inhibitors12008650.020 Why?
Female1020203795920.020 Why?
Finite Element Analysis120094310.020 Why?
Aged520201629440.020 Why?
Organoplatinum Compounds120084080.020 Why?
Antineoplastic Agents12009136550.020 Why?
Young Adult32016563500.010 Why?
Prognosis22016290100.010 Why?
Humans1020207420880.010 Why?
Cohort Studies22016404500.010 Why?
Sensitivity and Specificity12016147200.010 Why?
Risk1201396790.010 Why?
Chemotherapy, Adjuvant1200934710.010 Why?
Drug Administration Schedule1200849290.010 Why?
Retrospective Studies32016770980.010 Why?
Survival Analysis12012102480.010 Why?
Disease-Free Survival1200968910.010 Why?
Logistic Models12013134030.010 Why?
Models, Theoretical1200935840.010 Why?
Combined Modality Therapy1200986210.010 Why?
Enzyme Inhibitors1200838000.010 Why?
Membrane Proteins1201378730.010 Why?
Positron-Emission Tomography1201262590.010 Why?
Computer Simulation1200961910.010 Why?
Reproducibility of Results12013198620.010 Why?
Drug Resistance, Neoplasm1200851630.010 Why?
Prospective Studies12016531870.010 Why?
Risk Assessment12012233200.010 Why?
Tomography, X-Ray Computed12013200860.010 Why?
Magnetic Resonance Imaging12016353420.010 Why?
Algorithms12009138530.010 Why?
Risk Factors12016721450.010 Why?
Time Factors12009400540.000 Why?
Follow-Up Studies12009390040.000 Why?
Child, Preschool12009409550.000 Why?
Child12009774780.000 Why?
Adolescent12009856490.000 Why?
Animals120091685610.000 Why?
Ryu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.